A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma (Q33387524)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma |
scientific article |
Statements
1 reference
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma (English)
1 reference
Gairin Dancey
1 reference
John Violet
1 reference
Alessandra Malaroda
1 reference
Alan J Green
1 reference
Surinder K Sharma
1 reference
Shokri Othman
1 reference
Sweta Parker
1 reference
John Buscombe
1 reference
Natalie Griffin
1 reference
Pei-San Chan
1 reference
Anmol Malhotra
1 reference
Nicholas Woodward
1 reference
Alan Ramsay
1 reference
Philip Ross
1 reference
T Andrew Lister
1 reference
Peter Amlot
1 reference
Richard Begent
1 reference
Christopher McNamara
1 reference
1 December 2009
1 reference
1 reference
Identifiers
1 reference